Alteration in the liver metabolome of rats with metabolic syndrome after treatment with Hydroxytyrosol. A Mass Spectrometry And Nuclear Magnetic Resonance - based metabolomics study

Talanta

Volumn 178, Issue , 2018, Pages 246-257

  Dagla, Ioanna ^a   Benaki, Dimitra ^a   Baira, Eirini ^a   Lemonakis, Nikolaos ^a   Poudyal, Hemant ^b   Brown, Lindsay ^c   Tsarbopoulos, Anthony ^d   Skaltsounis, Alexios Leandros ^a   Mikros, Emmanouel ^a   Gikas, Evagelos ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

Hydroxytyrosol; Metabolic syndrome; Metabolomics; MS; NMR

Indexed keywords

BIOACTIVITY; CARBOHYDRATES; CARDIOLOGY; DISEASES; FATTY ACIDS; LIPIDS; LIQUID CHROMATOGRAPHY; MAGNETIC LEVITATION VEHICLES; MASS SPECTROMETRY; METABOLISM; MULTIVARIANT ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIVE OIL; PLANTS (BOTANY); QUALITY CONTROL; RATS; RELIABILITY ANALYSIS;

ANTI-OXIDANT ACTIVITIES; HIGH RESOLUTION MASS SPECTROMETRY; HYDROXYTYROSOL; METABOLIC SYNDROMES; METABOLOMICS; MULTIPLE INTERNAL STANDARDS; NUCLEAR MAGNETIC RESONANCE (NMR); ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

NUCLEAR MAGNETIC RESONANCE;

3,4-DIHYDROXYPHENYLETHANOL; PHENETHYL ALCOHOL;

ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECT; LIVER; MALE; MASS SPECTROMETRY; METABOLIC SYNDROME X; METABOLISM; METABOLOME; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT; WISTAR RAT;

ANIMALS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; METABOLIC SYNDROME; METABOLOME; METABOLOMICS; PHENYLETHYL ALCOHOL; RATS; RATS, WISTAR;

EID: 85029707140     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2017.09.029     Document Type: Article

References (49)

1. Alberti, K.G.M.M., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K. a., Fruchart, J.C., James, W.P.T., Loria, C.M., Smith, S.C., Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; and international association for the study of obesity. Circulation 120 (2009), 1640–1645, 10.1161/CIRCULATIONAHA.109.192644.
2. Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., Garg, R., Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111 (2005), 1448–1454, 10.1161/01.CIR.0000158483.13093.9D.
3. Moreira, M.C.D.S., Pinto, I.S.D.J., Mourão, A.A., Fajemiroye, J.O., Colombari, E., Reis, Â. A.D.S., Freiria-Oliveira, A.H., Ferreira-Neto, M.L., Pedrino, G.R., Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome?. Front. Physiol. 6 (2015), 1–11, 10.3389/fphys.2015.00234.
4. Guilherme, A., Virbasius, J.V., Puri, V., Czech, M.P., Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9 (2010), 367–377, 10.1038/nrm2391.Adipocyte.
5. Venturini, D., Simão, A.N.C., Scripes, N.A., Bahls, L.D., Melo, P. A.S., Belinetti, F.M., Lozovoy, M.A.B., Dichi, I., Evaluation of oxidative stress in overweight subjects with or without metabolic syndrome. Obesity 20 (2012), 2361–2366, 10.1038/oby.2012.130.
6. Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., Shimomura, I., Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Investig. 114 (2004), 1752–1761, 10.1172/JCI200421625.
7. Manuscript, A., Potential, T., With, L., Dysfunction, M., Molecular mechanism of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55 (2006), 1–15, 10.2337/diabetes.Molecular.
8. Sparks, L.M., Xie, H., Koza, R.A., Mynatt, R., Hulver, M.W., Bray, G.A., Smith, S.R., Required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes, 54, 2005.
9. Petersen, K.F., Befroy, D., Dufour, S., Dziura, J., Rothman, D.L., Dipietro, L., Cline, G.W., Gerald, I., NIH Public Access 300 (2010), 1140–1142, 10.1126/science.1082889.Mitochondrial.
10. Vial, G., Dubouchaud, H., Couturier, K., Cottet-Rousselle, C., Taleux, N., Athias, A., Galinier, A., Casteilla, L., Leverve, X.M., Effects of a high-fat diet on energy metabolism and ROS production in rat liver. J. Hepatol. 54 (2011), 348–356, 10.1016/j.jhep.2010.06.044.
11. Williams, D.E.M., Prevost, A.T., Whichelow, M.J., Cox, B.D., Day, N.E., Wareham, N.J., A cross-sectional study of dietary patterns with glucose intolerance and other features of the metabolic syndrome,. Br. J. Nutr. 44 (2016), 257–266.
12. Wirfält, E., Hedblad, B., Gullberg, B., Mattisson, I., Andrén, C., Rosander, U., Janzon, L., Food patterns and components of the metabolic syndrome in men and women : a cross-sectional study within the Malmö diet and cancer cohort. Am. J. Epidemiol. 154 (2001), 1150–1159.
13. Pereira, M.A., Jacobs, D.R. Jr., Van Horn, L., Slattery, M.L., Kartashov, A.I., Ludwig, D.S., Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the cardia study. JAMA 287 (2002), 2081–2089.
14. Pérez-López, F.R., Chedraui, P., Haya, J., Cuadros, J.L., Effects of the Mediterranean diet on longevity and age-related morbid conditions. Maturitas 64 (2009), 67–79, 10.1016/j.maturitas.2009.07.013.
15. Babio, N., Bulló, M., Salas-Salvadó, J., Mediterranean diet and metabolic syndrome: the evidence. Public Health Nutr. 12 (2009), 1607–1617, 10.1017/S1368980009990449.
16. Velázquez-López, L., Santiago-Díaz, G., Nava-Hernández, J., Muñoz-Torres, A.V., Medina-Bravo, P., Torres-Tamayo, M., Mediterranean-style diet reduces metabolic syndrome components in obese children and adolescents with obesity. BMC Pediatr., 14, 2014, 175, 10.1186/1471-2431-14-175.
17. Poudyal, H., Campbell, F., Brown, L., Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate –, high fat – fed rats 1 – 3. J. Nutr., 2010, 10.3945/jn.109.117812.In.
18. Cao, K., Xu, J., Zou, X., Li, Y., Chen, C., Zheng, A., Li, H., Li, H., Szeto, I.M.Y., Shi, Y., Long, J., Liu, J., Feng, Z., Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice. Free Radic. Biol. Med. 67 (2014), 396–407, 10.1016/j.freeradbiomed.2013.11.029.
19. Umeno, A., Takashima, M., Murotomi, K., Nakajima, Y., Koike, T., Matsuo, T., Yoshida, Y., Radical-scavenging activity and antioxidative effects of olive leaf components oleuropein and hydroxytyrosol in comparison with homovanillic alcohol. J. Oleo Sci. 64 (2015), 793–800.
20. Panchal, S.K., Brown, L., Rodent models for metabolic syndrome research. J. Biomed. Biotechnol., 2011, 2011, 10.1155/2011/351982.
21. Holmes, E., Wilson, I.D., Nicholson, J.K., Metabolic phenotyping in health and disease. Cell 134 (2008), 714–717, 10.1016/j.cell.2008.08.026.
22. Puchades-Carrasco, L., Pineda-Lucena, A., Metabolomics in pharmaceutical research and development. Curr. Opin. Biotechnol. 35 (2015), 73–77, 10.1016/j.copbio.2015.04.004.
23. Nicholson, J.K., Lindon, J.C., Holmes, E., “Metabonomics”: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29 (1999), 1181–1189, 10.1080/004982599238047.
24. Poudyal, H., Lemonakis, N., Efentakis, P., Gikas, E., Halabalaki, M., Andreadou, I., Skaltsounis, L., Brown, L., Hydroxytyrosol ameliorates metabolic, cardiovascular and liver changes in a rat model of diet-induced metabolic syndrome: pharmacological and metabolism-based investigation. Pharmacol. Res. 117 (2017), 32–45, 10.1016/j.phrs.2016.12.002.
25. Lemonakis, N., Poudyal, H., Halabalaki, M., Brown, L., Tsarbopoulos, A., Skaltsounis, A.-L., Gikas, E., The LC–MS-based metabolomics of hydroxytyrosol administration in rats reveals amelioration of the metabolic syndrome. J. Chromatogr. B 1041–1042 (2017), 45–59, 10.1016/j.jchromb.2016.12.020.
26. Wu, H., Southam, A.D., Hines, A., Viant, M.R., High-throughput tissue extraction protocol for NMR- and MS-based metabolomics. Anal. Biochem. 372 (2008), 204–212, 10.1016/j.ab.2007.10.002.
27. Beltran, A., Suarez, M., Rodríguez, M.A., Vinaixa, M., Samino, S., Arola, L., Correig, X., Yanes, O., Assessment of compatibility between extraction methods for NMR- and LC/MS-based metabolomics. Anal. Chem. 84 (2012), 5838–5844, 10.1021/ac3005567.
28. Libiseller, G., Dvorzak, M., Kleb, U., Gander, E., Eisenberg, T., Madeo, F., Neumann, S., Trausinger, G., Sinner, F., Pieber, T., Magnes, C., IPO: a tool for automated optimization of XCMS parameters. BMC Bioinform., 16, 2015, 118, 10.1186/s12859-015-0562-8.
29. S, G., Smith, Colin A., Want, Elizabeth J., O'Maille, Grace, Abagyan, Ruben, LC / MS preprocessing and analysis with xcms. Anal. Chem. 78 (2006), 779–787.
30. Benton, H.P., Wong, D.M., Trauger, S.A., Siuzdak, G., Processing tandem mass spectrometry data for metabolite identification and structural characterization. Anal. Chem. 80 (2008), 6382–6389, 10.1021/ac800795f.XCMS.
31. Redestig, H., Fukushima, A., Stenlund, H., Moritz, T., Arita, M., Saito, K., Kusano, M., Compensation for systematic cross-contribution improves normalization of mass spectrometry based metabolomics data. Anal. Chem. 81 (2009), 7974–7980, 10.1021/ac901143w.
32. Sysi-Aho, M., Katajamaa, M., Yetukuri, L., Oresic, M., Normalization method for metabolomics data using optimal selection of multiple internal standards. BMC Bioinform., 8, 2007, 93, 10.1186/1471-2105-8-93.
33. Veselkov, K.A., Vingara, L.K., Masson, P., Robinette, S.L., Want, E., Li, J.V., Barton, R.H., Boursier-Neyret, C., Walther, B., Ebbels, T.M., Pelczer, I., Holmes, E., Lindon, J.C., Nicholson, J.K., Optimized preprocessing of ultra-performance liquid chromatography/mass spectrometry urinary metabolic profiles for improved information recovery. Anal. Chem. 83 (2011), 5864–5872, 10.1021/ac201065j.
34. Ahdesmäki, M., Strimmer, K., Feature selection in omics prediction problems using cat scores and false nondiscovery rate control. Ann. Appl. Stat. 6 (2012), 503–519, 10.1214/09-AOAS277.
35. Zuber, V., Strimmer, K., Gene ranking and biomarker discovery under correlation. Bioinformatics 25 (2009), 2700–2707, 10.1093/bioinformatics/btp460.
36. Lee, J., Park, J., Lim, M., Seong, S.J., Seo, J.J., Park, S.M., Lee, H.W., Yoon, Y.-R., Quantile Normalization approach for liquid chromatography-mass spectrometry-based metabolomic data from healthy human volunteers. Anal. Sci. 28 (2012), 801–805, 10.2116/analsci.28.801.
37. Callister, S.J., Barry, R.C., Adkins, J.N., Johnson, E.T., Qian, W., Webb-Robertson, B.-J.M., Smith, R.D., Lipton, M.S., Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics. J. Proteom. 5 (2006), 277–286, 10.1016/j.drugalcdep.2008.02.002.A.
38. Katajamaa, M., Orešič, M., Data processing for mass spectrometry-based metabolomics. J. Chromatogr. A 1158 (2007), 318–328, 10.1016/j.chroma.2007.04.021.
39. Alonso, A., Marsal, S., JuliÃ, A., Analytical methods in untargeted metabolomics: state of the Art in 2015. Front. Bioeng. Biotechnol. 3 (2015), 1–20, 10.3389/fbioe.2015.00023.
40. Brock, G., Pihur, V., Datta, S., Datta, S., clValid: an R package for cluster validation. J. Stat. Softw. 25 (2008), 1–28.
41. Lynn, K., Cheng, M., Chen, Y., Hsu, C., Chen, A., Lih, T.M., Metabolite identification for mass spectrometry-based metabolomics using multiple types of correlated ion information. Anal. Chem. 87 (2015), 2143–2151, 10.1021/ac503325c.
42. Wishart, D.S., Jewison, T., Guo, A.C., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., Yallou, F., Bjorndahl, T., Perez-Pineiro, R., Eisner, R., Allen, F., Neveu, V., Greiner, R., Scalbert, A., HMDB 3.0-The Human Metabolome Database in 2013. Nucleic Acids Res. 41 (2013), 801–807, 10.1093/nar/gks1065.
43. Yore, M.M., Syed, I., Moraes-Vieira, P.M., Zhang, T., Herman, M.A., Homan, E.A., Patel, R.T., Lee, J., Chen, S., Peroni, O.D., Dhaneshwar, A.S., Hammarstedt, A., Smith, U., McGraw, T.E., Saghatelian, A., Kahn, B.B., Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell 159 (2014), 318–332, 10.1016/j.cell.2014.09.035.
44. Holst, J.J., The physiology of glucagon-like peptide 1. Physiol. Rev., 2007, 1409–1439, 10.1152/physrev.00034.2006.
45. Ichimura, A., Hirasawa, A., Poulain-Godefroy, O., Bonnefond, A., Hara, T., Yengo, L., Kimura, I., Leloire, A., Liu, N., Iida, K., Choquet, H., Besnard, P., Lecoeur, C., Vivequin, S., Ayukawa, K., Takeuchi, M., Ozawa, K., Tauber, M., Maffeis, C., Morandi, A., Buzzetti, R., Elliott, P., Pouta, A., Jarvelin, M.-R., Korner, A., Kiess, W., Pigeyre, M., Caiazzo, R., Van Hul, W., Van Gaal, L., Horber, F., Balkau, B., Levy-Marchal, C., Rouskas, K., Kouvatsi, A., Hebebrand, J., Hinney, A., Scherag, A., Pattou, F., Meyre, D., Koshimizu, T., Wolowczuk, I., Tsujimoto, G., Froguel, P., Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483 (2012), 350–354, 10.1038/nature10798.
46. Eisinger, K., Krautbauer, S., Hebel, T., Schmitz, G., Aslanidis, C., Liebisch, G., Buechler, C., Lipidomic analysis of the liver from high-fat diet induced obese mice identifies changes in multiple lipid classes. Exp. Mol. Pathol. 97 (2014), 37–43, 10.1016/j.yexmp.2014.05.002.
47. Puri, P., Baillie, R.A., Wiest, M.M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M.J., Sanyal, A.J., A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 46 (2007), 1081–1090, 10.1002/hep.21763.
48. Rodríguez-Morato, J., Xicota, L., Fito, M., Farre, M., Dierssen, M., De la Torre, R., Potential role of olive oil phenolic compounds in the prevention of neurodegenerative diseases. Molecules 20 (2015), 4655–4680, 10.3390/molecules20034655.
49. Hundal, R.S., Krssak, M., Dufour, S., Laurent, D., Lebon, V., Chandramouli, V., Inzucchi, S.E., Schumann, W.C., Petersen, K.F., Landau, B.R., Shulman, G.I., Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49 (2000), 2063–2069, 10.2337/diabetes.49.12.2063.